Monitoring intraocular proangiogenic and profibrotic cytokines within 7 days after adjunctive anti‐vascular endothelial growth factor therapy for proliferative diabetic retinopathy-Reference-Cited by-同舟云学术

Monitoring intraocular proangiogenic and profibrotic cytokines within 7 days after adjunctive anti‐vascular endothelial growth factor therapy for proliferative diabetic retinopathy

Published:2021-07-14 Issue: Volume: Page:
ISSN:1755-375X
Container-title:Acta Ophthalmologica
language:en
Short-container-title:Acta Ophthalmol

Author:

Hu Zizhong¹^ORCID,Cao Xin¹,Chen Lu¹²,Su Yun¹³,Ji Jiangdong¹,Yuan Songtao¹,Fransisca Silvia¹,Mugisha Aime¹,Zou Wenjun¹⁴,Xie Ping¹^ORCID,Liu Qinghuai¹^ORCID

Affiliation:

1. Department of Ophthalmology The First Affiliated Hospital of Nanjing Medical University Nanjing China

2. Xuzhou Key Laboratory of Ophthalmology The Municipal Affiliated Hospital of Xuzhou Medical UniversityEye Institute of Xuzhou Xuzhou China

3. Eye Hospital Department of Ophthalmology The Fourth School of Clinical Medicine Nanjing Medical University Nanjing China

4. Department of Ophthalmology The Affiliated Wuxi No.2 People's Hospital of Nanjing Medical University Wuxi China

Funder

Key Project of Research and Development Plan of Hunan Province

National Natural Science Foundation of China

Natural Science Foundation of Jiangsu Province

Publisher

Wiley

Subject

Ophthalmology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/aos.14957

Reference34 articles.

1. Ziv‐aflibercept versus bevacizumab administration prior to diabetic vitrectomy: a randomised and controlled trial;Aleman I;Br J Ophthalmol,2019

2. Tractional retinal detachment following intravitreal bevacizumab (Avastin) in patients with severe proliferative diabetic retinopathy;Arevalo JF;Br J Ophthalmol,2008

3. Change in diabetic retinopathy through 2 years: secondary analysis of a randomized clinical trial comparing aflibercept, bevacizumab, and ranibizumab;Bressler SB;JAMA Ophthalmol,2017

4. Preoperative bevacizumab administration in proliferative diabetic retinopathy patients undergoing vitrectomy: a randomized and controlled trial comparing interval variation;Castillo J;Am J Ophthalmol,2017

5. Efficacy of intravitreal ranibizumab injections in the treatment of vitreous hemorrhage related to proliferative diabetic retinopathy;Chelala E;Retina (Philadelphia Pa.),2018

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Intravitreal conbercept injection with panretinal photocoagulation for high-risk proliferative diabetic retinopathy with vitreous hemorrhage;International Journal of Ophthalmology;2024-06-18

2. Calcium dobesilate combined with candesartan in the treatment of proliferative diabetic retinopathy and its effect on TGF b1, VEGF and IL 19 levels in the vitreous humor;Tropical Journal of Pharmaceutical Research;2024-04-14

3. New Approaches to Surgical Treatment of Patients with Advanced Stage of Proliferative Diabetic Retinopathy;Ophthalmology in Russia;2024-03-31

4. High Vasohibin-2 expression correlated with autophagy in proliferative diabetic retinopathy;Experimental Eye Research;2024-03

5. Vascular Inflammation Attributed by IL-6 and Thrombomodulin in Patients with Impaired Glucose Tolerance and Type 2 Diabetes Visiting a Local Hospital;Pakistan Journal of Zoology;2024